Alira Health

Alira Health
Contact us
Alira Health
Menu
Home > Education Hub > Event: World Drug Safety Congress

Event: World Drug Safety Congress

October 20-21, 2021 | Boston, MA

Events
Category:
Pharma
Published on:
October 13, 2021

The World Drug Safety Congress Americas will bring together 600+ top leaders and stakeholders in biopharma to discuss the key challenges they are facing in pharmacovigilance and device safety.

Explore strategies in data management & signal detection, showcase how AI & machine learning have improved PV processes, discuss the challenges creating a PV strategy for advanced therapies, and collaborate on medical device safety strategies.

This conference is the largest commercial gathering of PV professionals in the world.

Who is attending?

Chris Rao

Vice President, Clinical Development

Kenny Carberry

Associate Director, Clinical Development

Christine Peckman 

Director, Pharmacovigilance

Click here to book a meeting

Related news

Articles July 24, 2026
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Drug Delivery MedTech Pharma
Articles May 12, 2026
Frequently Asked Questions on the Strategic Value of Dual Branding in Pharma
Discover how dual branding in pharma enables pricing flexibility and expands access, and how to design a strategy that protects value and withstands scrutiny.
Interview Market Access Pharma
News December 8, 2025
Alira Health Advises Guala Closures on Acquisition of KWK
We are pleased to have served as commercial due diligence (CDD) advisors to Guala Closures, a global leader in specialty closure solutions, supporting its acquisition of KWK, an Austrian(...)
CDD MedTech Pharma
News October 23, 2025
Global Drug Delivery Systems (DDS) Market Transforms Amid New Pharma Demands
Alira Health today released its 2025 Global Drug Delivery System Trends Report, highlighting the rapid evolution of the global drug delivery systems (DDS) market.
Drug Delivery Pharma
Case Studies May 30, 2025
Pharma Company Advances Fair Trials Representation With Structured Patient Engagement Strategy
A global pharmaceutical company focused on respiratory, neonatology, rare diseases, and specialty care lacked a systematic approach to enhance the recruitment and retention of diverse(...)
Patient Engagement Pharma Rare Disease
Case Studies March 20, 2025
Pharma Company Defines Advocacy Strategy Through Data-Driven Patient Association Mapping
Alira Health mapped 253 CVRM patient advocacy groups across 11 countries, delivering a data-driven strategy to optimize partnerships, advocacy efforts, and differentiation.
Patient Advocacy Patient Engagement Pharma
Case Studies March 6, 2025
Rare Disease Pharma Maps Rare Cholestatic Liver Disease Journey for Targeted Patient Engagement
A global pharmaceutical company specializing in rare diseases, oncology, and neuroscience sought to analyze the patient journey for progressive familial intrahepatic cholestasis (PFIC).
Patient Centricity Pharma Rare Disease
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.